Number of doses received previously

Age at presentation

Age at 1st dose of PCV

Age at 2nd dose of PCV

Age at 3rd dose of PCV

Number of further primary dose(s) needed

Number of booster dose(s) at age ≥12 months

None

<12 months

na

na

na

2

1

12–59 months

na

na

na

1

None

1

<12 months

<12 months

na

na

1

1

12–59 months

<12 months

na

na

None

1

12–59 months

≥12 months

na

na

None

None

2

<12 months

<12 months

<12 months

na

None

1

12–59 months

<12 months

<12 months

na

None

1

12–59 months

<12 months

≥12 months

na

None

None

3

<12 months

<12 months

<12 months

<12 months

None

1

12–59 months

<12 months

<12 months

<12 months

None

None (not routinely recommended but may be given to maximise individual protection)

na = not applicable

Last updated: 
3 June 2020
Last reviewed: 
3 June 2020